Converting Enzyme Inhibitor Ramipril Stimulates Prostacyclin Synthesis by Isolated Rat Aorta: Evidence for a Kinin-dependent Mechanism

Overview

Journal Klin Wochenschr

Specialty General Medicine

Date 1986 Aug 15

PMID 3020312

Citations 6

Authors

H Scherf

R PIETSCH

G Landsberg

H J Kramer

R Dusing

Affiliations

Soon will be listed here.

Abstract

The present study was performed to investigate the effect of the angiotensin I-converting enzyme inhibitor ramipril on vascular synthesis of prostacyclin (PGI2). Administration of ramipril (Hoe 498) to rats significantly stimulated prostacyclin (PGI2) synthesis, quantified by radioimmunoassay of its stable hydrolysis product 6-keto-PGF1 alpha, by portions of the animals' isolated aorta. This effect was maximal at a dose range of 10(-7) mol/kg ramipril. The addition of the active ramipril metabolite ramipril diacid directly into the incubation buffer at final concentrations of 10(-9), 10(-6), and 10(-4) M resulted in a dose-dependent stimulation of 6-keto-PGF1 alpha released by isolated aortic tissue. Pretreatment of rats with aprotinin (40,000 U s.c. 60 min before the incubations) attenuated the ramipril-induced effect on aortic 6-keto-PGF1 alpha synthesis. Our results show that the angiotensin I-converting enzyme inhibitor ramipril stimulates PGI2 synthesis in vascular tissue and that this effect may be secondary to changes in the activity of the kinin system.

Citing Articles

Mechanism of VEGF expression by high glucose in proximal tubule epithelial cells.

Feliers D, Kasinath B Mol Cell Endocrinol. 2009; 314(1):136-42.

PMID: 19765632 PMC: 2783935. DOI: 10.1016/j.mce.2009.09.009.

Tonic stimulation of renin gene expression by nitric oxide is counteracted by tonic inhibition through angiotensin II.

Schricker K, Hegyi I, Hamann M, Kaissling B, Kurtz A Proc Natl Acad Sci U S A. 1995; 92(17):8006-10.

PMID: 7644529 PMC: 41275. DOI: 10.1073/pnas.92.17.8006.

Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosis.

Linz W, Wiemer G, Schaper J, Zimmermann R, Nagasawa K, Gohlke P Mol Cell Biochem. 1995; 147(1-2):89-97.

PMID: 7494560 DOI: 10.1007/BF00944788.

Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril.

Linz W, Scholkens B, Kaiser J, Just M, Qi B, Albus U Cardiovasc Drugs Ther. 1989; 3(6):873-82.

PMID: 2535056 DOI: 10.1007/BF01869575.

Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders.

Todd P, Benfield P Drugs. 1990; 39(1):110-35.

PMID: 2138076 DOI: 10.2165/00003495-199039010-00009.

References

Moncada S, Vane J . Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol Rev. 1978; 30(3):293-331. View

Geiger R . Chemistry of the inhibitors of the renin-angiotensin system. Arzneimittelforschung. 1984; 34(10B):1386-91. View

Sullivan J, PATRICK D . Release of prostaglandin I2-like activity from the rat aorta: effect of captopril, furosemide, and sodium. Prostaglandins. 1981; 22(4):575-85. DOI: 10.1016/0090-6980(81)90067-8. View

Felder K, Witte P . Effects of the new oral angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) in essential hypertension. Arzneimittelforschung. 1984; 34(10B):1452-4. View

Uglesity A, Kreisberg J, Levine L . Stimulation of arachidonic acid metabolism in rat kidney mesangial cells by bradykinin, antidiuretic hormone, and their analogues. Prostaglandins Leukot Med. 1983; 10(1):83-93. DOI: 10.1016/s0262-1746(83)80023-7. View

Dusing R, Scherhag R, Landsberg G, Glanzer K, Kramer H . The converting enzyme inhibitor captopril stimulates prostacyclin synthesis by isolated rat aorta. Eur J Pharmacol. 1983; 91(4):501-4. DOI: 10.1016/0014-2999(83)90176-0. View

Unger T, Fleck T, Ganten D, Lang R, Rettig F . 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498): antihypertensive action and persistent inhibition of tissue converting enzyme activity in spontaneously hypertensive rats. Arzneimittelforschung. 1984; 34(10B):1426-30. View

Dusing R, Scherhag R, Glanzer K, Budde U, Kramer H . Dietary linoleic acid deprivation: effects on blood pressure and PGI2 synthesis. Am J Physiol. 1983; 244(2):H228-33. DOI: 10.1152/ajpheart.1983.244.2.H228. View

Scholkens B, Becker R, Kaiser J . Cardiovascular and antihypertensive activities of the novel non-sulfhydryl converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498). Arzneimittelforschung. 1984; 34(10B):1417-25. View

10.

McGiff J . Interactions of prostaglandins with the kallikrein-kinin and renin-angiotensin systems. Clin Sci (Lond). 1980; 59 Suppl 6:105s-116s. DOI: 10.1042/cs059105s. View

11.

Dusing R, Scherhag R, Tippelmann R, Budde U, Glanzer K, Kramer H . Arachidonic acid metabolism in isolated rat aorta. Dependence of prostacyclin biosynthesis on extracellular potassium concentration. J Biol Chem. 1982; 257(4):1993-6. View

12.

Dusting G, Mullins E, Nolan R . Prostacyclin (PGI2) release accompanying angiotensin conversion in rat mesenteric vasculature. Eur J Pharmacol. 1981; 70(2):129-37. DOI: 10.1016/0014-2999(81)90207-7. View

13.

Pace-Asciak C, Carrara M, Nicolaou K . Prostaglandin I2 has more potent hypotensive properties than prostaglandin E2 in the normal and spontaneously hypertensive rat. Prostaglandins. 1978; 15(6):999-1003. DOI: 10.1016/0090-6980(78)90042-4. View

14.

Galler M, Backenroth R, Folkert V, Schlondorff D . Effect of converting enzyme inhibitors on prostaglandin synthesis by isolated glomeruli and aortic strips from rats. J Pharmacol Exp Ther. 1982; 220(1):23-8. View

15.

Vinci J, HORWITZ D, Zusman R, Pisano J, Catt K, KEISER H . The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man. Hypertension. 1979; 1(4):416-26. DOI: 10.1161/01.hyp.1.4.416. View